Details for 2016176456
Up to date per 03.04.2026
Actions
Details for 2016176456
Granted/Registered
European Patent
22.02.2017 A
05.09.2018 B1
29.08.2008
US
93234 P
G01N 33/50 20060101AFI20161031BHEP
Owner
Immedica Pharma ABNorrtullsgatan 15113 29 StockholmSE
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1014 WienAT
Inventor
SCHARSCHMIDT, BruceHyperion Therapeutics 601 Gateway Boulevard Suite 200 South San Francisco, CA 94080US
Information about Fees